Epigenetics and DNA methylation come of age in toxicology

Toxicological Sciences

Volumn 67, Issue 1, 2002, Pages 11-16

  Watson, Rebecca E ^a   Goodman, Jay I ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL AGENT; DNA;

ARTICLE; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DNA METHYLATION; GENE MUTATION; GENETIC TOXICOLOGY; GENOME ANALYSIS; HERITABILITY; HUMAN; NONHUMAN; PHENOTYPE; RISK ASSESSMENT;

EID: 0036094163     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/67.1.11     Document Type: Article

References (58)

1. DNA methylation in folate deficiency: Use of CpG methylase
2. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
3. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
4. The DNA methyltransferases of mammals
5. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation
6. High sensitivity mapping of methylated cytosines
7. Cell proliferation in carcinogenesis
8. Alterations in DNA methylation may play a variety of roles in carcinogenesis
9. Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration
10. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells
11. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis
12. Methylation analysis on individual chromosomes: Improved protocol for bisulphite genomic sequencing
13. Cancer epigenetics takes center stage
14. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive, arbitrarily primed PCR
15. Altered DNA methylation: A secondary mechanism involved in carcinogenesis
16. Expression of DNA methyltransferase gene in mature and immature neurons as well as proliferating cells in mice
17. Inheritance of phenotype in mammalian cells: Genetic vs. epigenetic mechanisms
18. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
19. Mechanisms for the control of gene activity during development
20. Epigenetics and human disease
21. Genomic imprinting and cancer
22. The DNA methylation paradox
23. Methylated DNA and MeCP2 recruit histone deacetlyase to repress transcription
24. Activation of the p53 DNA damage-response pathway after inhibition of DNA methyltransferase by 5-aza-2′-deoxycytidine
25. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: A paradigm of gene-nutrient interactions in carcinogenesis
26. Epigenetic mechanisms of chemical carcinogenesis
27. DNA replication fidelity
28. Oncogenic mechanisms mediated by DNA methylation
29. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues
30. The role for DNA methylation in genomic imprinting
31. Beckwith-Wiedemann syndrome: Imprinting in clusters revisited
32. Epigenetic programming of differential gene expression in development and evolution
33. DNA methylation: Regulation of gene expression and role in the immune system
34. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers
35. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
36. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetlylase complex
37. Aberrant methylation of the estrogen receptor and e-cadherin 5′ CpG islands increases with malignant progression in human breast cancer
38. DNA methylation and chromatin modification
39. Behind the scenes of gene expression
40. Effect of chloroform on dichloroacetic acid- and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors in mice
41. Human morbid genetics revisited: Relevance of epigenetics
42. The marks, mechanisms, and memory of epigenetic states in mammals
43. Epigenetic reprogramming in mammalian development
44. The evolution of epigenetics
45. Nuclear cloning and epigenetic reprogramming of the genome
46. DNA methylation: Past, present and future directions
47. The human DNA methyltransferases (DNMTs) 1, 3a, and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors
48. DNA methylation in health and disease
49. Cell death and cell cycle perturbation in the developmental toxicity of the demethylating agent, 5-aza-2′-deoxycytidine
50. Expression of HLA class-I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′-deoxycytidine treatment
51. The imprinting box of the Prader-Willi/Angelman syndrome domain
52. The DNA methylation machinery as a therapeutic target
53. Molecular biology: Mothers setting boundaries
54. Modulators of gap junction: The scientific basis of epigenetic toxicology
55. Localization of the ICF syndrome to chromosome 20 by homozygosity mapping
56. Methods for evaluating chemical genotoxicity
57. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene
58. 5-Azacytidine changes gene expression and causes developmental arrest of early chick embryo